Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment
Bo Wu, Xiang Shi, Meixi Jiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 91
Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis
Wendi Kang, Xiang Qiu, Yingen Luo, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 46
Effects of Chemotherapy on the Immune System: Implications for Cancer Treatment and Patient Outcomes
Anirudh Sharma, Shivam Jasrotia, Ajay Kumar
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2551-2566
Closed Access | Times Cited: 45
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 33
Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer
Yonger Chen, Jian Liang, Shuxian Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications
Daoqi Zhu, Siying Zeng, Chao Su, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 16
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer
Shan Liu, Xingda Zhang, Wenzheng Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Harnessing cancer stem cell-derived exosomes to improve cancer therapy
Jianqiang Yang, Yong Teng
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 26
The emerging role of oral microbiota in oral cancer initiation, progression and stemness
Partha Jyoti Saikia, Lekhika Pathak, Shirsajit Mitra, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells
Youssef Al Hmada, Robert T. Brodell, Naji Kharouf, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 470-470
Open Access | Times Cited: 15
ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy
Kousalya Lavudi, Shreya Madhav Nuguri, Prashant Pandey, et al.
Life Sciences (2024) Vol. 356, pp. 123033-123033
Closed Access | Times Cited: 15
Immune cell networking in solid tumors: focus on macrophages and neutrophils
Irene Di Ceglie, Silvia Carnevale, Anna Rigatelli, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy
Suling Xu, Qing-Qing Wang, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 76, pp. 12-21
Closed Access | Times Cited: 12
Polymeric and non-polymeric oxaliplatin nanomedicine for cancer therapy: A comprehensive review
Mehrab Pourmadadi, Meysam Shaghaghi, Rabia Arshad, et al.
European Polymer Journal (2024) Vol. 208, pp. 112870-112870
Closed Access | Times Cited: 11
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies
Mohamed El‐Tanani, Syed Arman Rabbani, Shakta Mani Satyam, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 382-382
Open Access | Times Cited: 1
Crosstalk between GLTSCR1-deficient endothelial cells and tumour cells promotes colorectal cancer development by activating the Notch pathway
Lu Liu, Fengyan Han, Mengli Deng, et al.
Cell Death and Differentiation (2025)
Closed Access | Times Cited: 1
Breast cancer stem cells convert anti-tumor CD4+ T cells to pro-tumor T regulatory cells: Potential role of exosomal FOXP3
Udit Basak, Sourio Chakraborty, Sumon Mukherjee, et al.
Cellular Immunology (2025) Vol. 409-410, pp. 104931-104931
Closed Access | Times Cited: 1
Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy
Raefa Abou Khouzam, Bassam Janji, Jérôme Thiery, et al.
Seminars in Cancer Biology (2023) Vol. 97, pp. 104-123
Closed Access | Times Cited: 18
Cancer stem cells: a target for overcoming therapeutic resistance and relapse
Shuo Zhang, Rui Yang, Yujie Ouyang, et al.
Cancer Biology and Medicine (2024) Vol. 20, Iss. 12, pp. 985-1020
Open Access | Times Cited: 6
Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies
Erbao Chen, Zhilin Zou, Rongyue Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications
Zhengjun Lin, Guoqing Li, Ke Jiang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets
Julia Pospieszna, Hanna Dams-Kozłowska, Wachirawit Udomsak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10910-10910
Open Access | Times Cited: 14
Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells
Linheng Li, Roy A. Jensen
Cancer Research (2023) Vol. 83, Iss. 13, pp. 2096-2104
Open Access | Times Cited: 14
Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells
Xiao-Hai Song, Lan Yang, Xiuli Zheng, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top